Molecular hybridization of 4-azahexacyclo[5.4.1.02,6.03,10.05,9.08,11] dodecane-3-ol with sigma (σ) receptor ligands modulates off-target activity and subtype selectivity

被引:14
作者
Banister, Samuel D. [1 ]
Moussa, Iman A. [1 ]
Jorgensen, William T. [1 ]
Chua, Sook Wern [2 ]
Kassiou, Michael [1 ,2 ,3 ]
机构
[1] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia
[2] Brain & Mind Res Inst, Sydney, NSW 2050, Australia
[3] Univ Sydney, Discipline Med Radiat Sci, Sydney, NSW 2006, Australia
关键词
Trishomocubanes; Sigma receptors; CNS; Structure-activity relationships; ANTIPSYCHOTIC-DRUGS; HIGH-AFFINITY; IN-VITRO; BINDING; RELEASE; DOPAMINE; CLONING; TRISHOMOCUBANES; PROLIFERATION; PHARMACOLOGY;
D O I
10.1016/j.bmcl.2011.04.098
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)] dodecan-3-ols incorporating the respective arylalkyl subunits from several known sigma (sigma) receptor ligands were synthesized and evaluated for their affinity against sigma receptors and dopamine receptors. The hybrid trishomocubane-derived ligands (4-6) showed good selectivity for sigma(1) and sigma(2) receptors over multiple dopamine receptors. The molecular hybrid obtained from haloperidol and 4-azahexacyclo[ 5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)] dodecan-3-ol (4, sigma(1) K-i = 27 nM, sigma(2) K-i = 55 nM) showed reduced affinity for D-1-D-5 dopamine receptors when compared to haloperidol itself. The compound with the greatest sigma(1) affinity in the series, benzamide 4 (sigma(1) K-i = 7.6 nM, sigma(2) K-i = 225 nM) showed a complete reversal of the subtype selectivity displayed by the highly sigma(2) selective parent benzamide, RHM-2 (3, sigma(1) K-i = 10412 nM, sigma(2) K-i = 13.3 nM). (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3622 / 3626
页数:5
相关论文
共 48 条
[1]   The pharmacology of the novel and selective sigma ligand, PD 144418 [J].
Akunne, HC ;
Whetzel, SZ ;
Wiley, JN ;
Corbin, AE ;
Ninteman, FW ;
Tecle, H ;
Pei, Y ;
Pugsley, TA ;
Heffner, TG .
NEUROPHARMACOLOGY, 1997, 36 (01) :51-62
[2]   Effect of ploidy, recruitment, environmental factors, and tamoxifen treatment on the expression of sigma-2 receptors in proliferating and quiescent tumour cells [J].
Al-Nabulsi, I ;
Mach, RH ;
Wang, LM ;
Wallen, CA ;
Keng, PC ;
Sten, K ;
Childers, SR ;
Wheeler, KT .
BRITISH JOURNAL OF CANCER, 1999, 81 (06) :925-933
[3]   The sigma receptor as a ligand-regulated auxiliary potassium channel subunit [J].
Aydar, E ;
Palmer, CP ;
Klyachko, VA ;
Jackson, MB .
NEURON, 2002, 34 (03) :399-410
[4]   Oxo-bridged isomers of aza-trishomocubane sigma (σ) receptor ligands: Synthesis, in vitro binding, and molecular modeling [J].
Banister, Samuel D. ;
Moussa, Iman A. ;
Jordan, Meredith J. T. ;
Coster, Mark J. ;
Kassiou, Michael .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (01) :145-148
[5]   A multireceptorial binding reinvestigation on an extended class of σ ligands:: N-[ω-(Indan-1-yl and tetralin-1-yl)alkyl] derivatives of 3,3-dimethylpiperidine reveal high affinities towards σ1 and EBP sites [J].
Berardi, F ;
Ferorelli, S ;
Colabufo, NA ;
Leopoldo, M ;
Perrone, R ;
Tortorella, V .
BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (05) :1325-1335
[6]   The role of sigma receptors in depression [J].
Bermack, JE ;
Debonnel, G .
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 (03) :317-336
[7]   Modulation of serotonergic neurotransmission by short- and long-term treatments with sigma ligands [J].
Bermack, JE ;
Debonnel, G .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134 (03) :691-699
[8]   Radioreceptor binding profile of the atypical antipsychotic olanzapine [J].
Bymaster, FP ;
Calligaro, DO ;
Falcone, JF ;
Marsh, RD ;
Moore, NA ;
Tye, NC ;
Seeman, P ;
Wong, DT .
NEUROPSYCHOPHARMACOLOGY, 1996, 14 (02) :87-96
[9]   Is the σ2 receptor a histone binding protein? [J].
Colabufo, Nicola Antonio ;
Berardi, Francesco ;
Abate, Carmen ;
Contino, Marialessandra ;
Niso, Mauro ;
Perrone, Roberto .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (14) :4153-4158
[10]   Modulation of NMDA and dopaminergic neurotransmissions by sigma ligands: Possible implications for the treatment of psychiatric disorders [J].
Debonnel, G ;
deMontigny, C .
LIFE SCIENCES, 1996, 58 (09) :721-734